跳至主要内容
临床试验/NCT01520246
NCT01520246已完成不适用

Signaling in Tumorigenesis and Immunity

Children's Oncology Group0 个研究点目标入组 20 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
PDLIM2 expression patterns in cancer and control tissues

研究概览

简要总结

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors find better ways to treat cancer.

PURPOSE: This research trial studies gene expression in samples from patients with T-cell acute lymphoblastic leukemia.

详细描述

OBJECTIVES:

  • To test whether the tumor suppressor candidate gene PDLIM2 is downregulated in human cancers such as T-cell acute lymphoblastic leukemia (T-ALL) and to use the human T-lymphotropic virus 1 (HTLV-1)-mediated in vitro transformation of human T cells as control.

OUTLINE: Previously collected cancer and control tissues are analyzed for the expression patterns of PDLIM2 and other control genes. Human T-cells isolated from human blood are also co-cultured with HTLV-1-transformed T-cell lines.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 120 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

PDLIM2 expression patterns in cancer and control tissues

8-week survival of human T-cell co-cultured with HTLV-1-transformed T-cell lines

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验